BDBM492875 N-((5-chloro-1H- indazol-3-yl)methyl)-5- (4- methylbenzyl) nicotinamide::US10981893, Example 4

SMILES Cc1ccc(Cc2cncc(C(=O)NCc3n[nH]c4ccc(Cl)cc34)c2)cc1

InChI Key InChIKey=GYTIAVJQNUGOPW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492875   

TargetPlasma kallikrein(Human)
Attune Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 492875BDBM492875(US10981893, Example 4 | N-((5-chloro-1H- indazol-3...)
Affinity DataIC50: 5.50E+3nMAssay Description:The ability of the compounds disclosed herein to inhibit human plasma kallikrein activity was quantified according to the procedures below.A 10 mM so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent